Semaglutide weight loss results: what clinical trials actually found

STEP 1 trial: adults on semaglutide 2.4mg lost around 15% of body weight on average over 68 weeks, versus roughly 2.4% on placebo.
The newer 7.2mg Wegovy dose, approved by the MHRA in January 2026, reported around 20.7% average weight loss over 72 weeks in trials — closing the gap with tirzepatide 15mg.
Results build gradually over months; most people notice meaningful change between weeks 8 and 16, once titration is underway.
Stopping semaglutide typically leads to partial weight regain, which is why treatment decisions and duration are made with a prescriber, not at the counter.

In clinical trials, semaglutide at the 2.4mg weekly dose produced an average body-weight reduction of around 15% over 68 weeks, compared with roughly 2.4% for placebo, among adults with obesity who also made lifestyle changes. Those are the headline semaglutide weight loss results from the STEP 1 trial, published in the New England Journal of Medicine. The actual figure any individual reaches depends on their starting weight, how long they stay on treatment, which dose they reach, and how consistently they pair the medicine with reduced-calorie eating and movement. Wegovy (semaglutide for weight management) is a prescription-only medicine; a GPhC-registered prescriber has to assess whether it is clinically suitable for you before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How semaglutide results unfold over time — and what shapes them

Step 1: the slow build through titration (weeks 1–16)

Semaglutide does not arrive at full therapeutic strength on day one. The licensed schedule starts at 0.25mg weekly, stepping up roughly every four weeks through 0.5mg, 1.0mg and 1.7mg before reaching the 2.4mg maintenance dose. The early weeks are primarily about your body adjusting: appetite changes begin to register, but the scale is unlikely to move dramatically. Most people find noticeable progress arrives somewhere between weeks 8 and 16, once the dose has climbed past the halfway point of titration.

If you are curious about the earliest weeks specifically, our one-week results page sets realistic expectations for that initial period, and the four-week picture covers what the first full month of treatment typically looks like. Titration pace and whether you move to a higher dose are clinical decisions; your prescriber will review your response before any step up.

Step 2: the evidence base behind the 15% figure

The 15% average weight reduction from STEP 1 is a population mean across 1,961 adults with obesity who had no type 2 diabetes. Individual results spread around that average: some participants lost considerably more, others less. Roughly one third lost more than 20% of body weight. The NHS medicines page for semaglutide acknowledges this range and explains that results depend on consistent use alongside a calorie-reduced diet and increased physical activity.

The MHRA approved a dedicated single-dose 7.2mg pen in April 2026. In its supporting trials, participants reached around 20.7% average weight loss over 72 weeks, a figure that narrows the gap with the highest tirzepatide dose. It is worth noting that 7.2mg is the maximum and is reached after a full titration sequence; it is not a starting point. For a broader look at how Wegovy results compare with what the clinical record shows across different timeframes, the Wegovy weight loss results page covers that evidence in more depth.

Step 3: the factors that move results up or down

Researchers and clinicians are clear that semaglutide works as part of a package. The STEP 1 participants received dietary counselling alongside the injection; those in the placebo arm who received the same support still lost around 2.4% on average, which tells you something about the medicine's specific contribution. In practice, the people who see the strongest results tend to reach and sustain the maintenance dose, maintain adequate protein intake to preserve muscle mass, keep up some form of regular activity, and stay on treatment long enough for the medicine to work, typically at least six months before drawing conclusions.

Starting BMI, age, and whether any metabolic conditions are present all influence how the body responds. There is no reliable way to predict in advance exactly how much weight a specific individual will lose. That honest uncertainty is part of why treatment is clinician-led rather than a straightforward purchase.

What happens when semaglutide is stopped

The evidence on discontinuation is consistent and worth knowing before you start: weight tends to return, partially, after stopping. A follow-up study to STEP 1 found that one year after participants stopped semaglutide, around two thirds of the weight lost had been regained. This is not a failure of the medicine; it reflects the biology of appetite regulation, which returns towards its baseline once the drug is no longer present, and our page on how long semaglutide takes to clear the body explains the pharmacology behind that process.

This reality shapes how prescribers approach duration conversations, and why it matters to have ongoing clinical oversight rather than ordering a single pen and deciding for yourself. Our page on how long Wegovy takes to work addresses both the ramp-up and the longer arc of treatment. If you are thinking about whether semaglutide is the right fit (or how private treatment is priced) the Wegovy cost page lays out what a legitimate prescription service includes. When you feel ready to talk to someone clinical rather than read more articles, starting a free consultation is the next step. A named prescriber reads your answers the same day; no algorithm makes the call.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions